Who We Are

BCS2 is led by a management team with experience in the pharmaceutical industry and a proven track record in drug commercialisation

Stuart Gunzburg, PhD, MBA (CEO & Chief Scientific Officer): Dr. Gunzburg has over 30 years of experience in pharmaceutical R&D and drug delivery innovation. He is a former biotech CEO and equity analyst who has successfully led the translation of laboratory breakthroughs into commercial platforms. Additionally, he is an inventor on multiple patents related to nano-formulation and reformulated therapeutics.